Qingdao Baheal Medical INC. (301015.SZ) Key Statistics
$23.60SHZ: 301015.SZMarket Cap $13.63B
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Qingdao Baheal Medical INC. (301015.SZ), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
25.94
P/B ratioShare price divided by book value per share.
5.69
P/S ratioMarket value divided by annual revenue.
1.86
PEG ratioP/E divided by the earnings growth rate.
0.98
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
18.83
EV / RevenueEnterprise value against annual revenue.
2.14
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
3.86%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
38.85%
Operating marginRevenue left after operating costs.
9.41%
Net marginRevenue left after every cost, including tax and interest.
7.33%
Return on equityProfit as a percentage of shareholders’ equity.
24.76%
Return on assetsProfit as a percentage of total assets.
6.30%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.43
Quick ratioThe same, excluding inventory.
0.99
Debt to equityTotal borrowings against shareholders’ equity.
1.40
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$1.00
Book value per shareShareholders’ equity divided by shares outstanding.
$4.56
Shares outstandingShares currently issued.
525,624,077
Market capitalisationShare price times shares outstanding.
$13.63B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
2,493
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
2.20%
Payout ratioShare of profit paid out as dividends.
57.07%
Qingdao Baheal Medical INC. (301015.SZ) statistics — frequently asked questions
What is Qingdao Baheal Medical INC.'s P/E ratio?
Qingdao Baheal Medical INC. (301015.SZ) trades on a price-to-earnings ratio of 25.94.
What is Qingdao Baheal Medical INC.'s return on equity?
Qingdao Baheal Medical INC. (301015.SZ) reports a return on equity of 24.76%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Qingdao Baheal Medical INC. carry?
Qingdao Baheal Medical INC. (301015.SZ) has a debt-to-equity ratio of 1.40, which compares total borrowings with shareholders' equity.
What is Qingdao Baheal Medical INC.'s profit margin?
Qingdao Baheal Medical INC. (301015.SZ) keeps 7.33% of revenue as net profit after every cost, including tax and interest.